Treatment Effects of Narrative Exposure Therapy
1 other identifier
interventional
40
1 country
1
Brief Summary
This study compares Narrative Exposure Therapy with a Waiting list control group, both consists of traumatized patients with diagnosed Posttraumatic Stress Disorder. The main aim is to investigate if the patients psychiatric symptoms and levels of the stress hormone cortisol will improve more after Narrative Exposure Therapy than the Waiting list (i.e. no intervention).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_2
Started May 2007
Typical duration for phase_2
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2007
CompletedFirst Submitted
Initial submission to the registry
April 10, 2008
CompletedFirst Posted
Study publicly available on registry
April 17, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2009
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2010
CompletedApril 17, 2008
April 1, 2008
2.6 years
April 10, 2008
April 15, 2008
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Psychiatric symptoms
1 and 6 months after treatment
Secondary Outcomes (1)
Cortisol in saliva
1 and 6 months after treatment
Study Arms (2)
A
EXPERIMENTALTreatment group, receives Narrative Exposure Therapy immediately after first assessment. Patients are assessed 1 and 6 months after treatment.
B
NO INTERVENTIONWaiting list control group, receives no intervention for 3 months after first assessment. A second assessment is then administered and patients receives Narrative Exposure Therapy. Patients are assessed 1 and 6 months after treatment.
Interventions
Psychological treatment, with narration of positive and traumatic events in patients history, including "in vivo" exposure of traumatic events. The narrative is written down by the therapist.
Eligibility Criteria
You may qualify if:
- Posttraumatic Stress Disorder (PTSD)
- Age above 18 years
- Understands, speaks and writes Norwegian
- Informed, written consent
You may not qualify if:
- Active psychosis
- Active suicidality
- Serious self mutilation
- Active alcohol or drug abuse
- Serious dissociative symptoms
- Disease in nervous system or head injury
- Hormonal disease
- Pregnancy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Western Norway Violence and Traumatic Stress Resource Centre
Bergen, 5021, Norway
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Anne Marita Milde, PhD
University of Bergen
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
April 10, 2008
First Posted
April 17, 2008
Study Start
May 1, 2007
Primary Completion
December 1, 2009
Study Completion
November 1, 2010
Last Updated
April 17, 2008
Record last verified: 2008-04